MORI, SILVIA
MORI, SILVIA
Branch migration displacement assay with automated heuristic analysis for discrete DNA length measurement using DNA microarrays
2007 Pourmand, N; Caramuta, S; Villablanca, A; Mori, S; Karhanek, M; Wang, S; Davis, R
p160 Myb-binding protein interacts with Prep1 and inhibits its transcriptional activity
2007 Díaz, V; Mori, S; Longobardi, E; Menendez, G; Ferrai, C; Keough, R; Bachi, A; Blasi, F
Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism
2008 Oriente, F; Diaz, L; Miele, C; Iovino, S; Mori, S; Diaz, V; Troncone, G; Cassese, A; Formisano, P; Blasi, F; Beguinot, F
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition
2009 Matafora, V; D'Amato, A; Mori, S; Blasi, F; Bachi, A
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years
2011 GAMBACORTI PASSERINI, C; Antolini, L; Piazza, R; Guilhot, F; Deininger, M; Fava, C; Nagler, A; Morra, E; Abruzzese, E; D'Emilio, A; Stagno, F; le Coutre, P; Monroy, R; Santini, V; Pane, F; Giraldo, P; Assouline, S; Durosinmi, M; Leeksma, O; Pogliani, E; Pavesi, F; Puttini, M; Rizzo, C; Dilda, I; Mori, S; Kim, D; Valsecchi, M
Myb-Binding Protein 1A (MYBBP1A) Is Essential for Early Embryonic Development, Controls Cell Cycle and Mitosis, and Acts as a Tumor Suppressor
2012 Mori, S; Bernardi, R; Laurent, A; Resnati, M; Crippa, A; Gabrieli, A; Keough, R; Gonda, T; Blasi, F
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis
2014 Mori, S; Vagge, E; le Coutre, P; Abruzzese, E; Martino, B; Pungolino, E; Elena, C; Pierri, I; Assouline, S; D'Emilio, A; Gozzini, A; Giraldo, P; Stagno, F; Iurlo, A; Luciani, M; De Riso, G; Kim, D; Pirola, A; Petroccione, A; Lodolo D’Oria, A; Crivori, P; Piazza, R; GAMBACORTI PASSERINI, C
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study
2015 Mori, S; Vagge, E; Le Coutre, P; Abruzzese, E; Martino, B; Pungolino, E; Elena, C; Pierri, I; Assouline, S; D'Emilio, A; Gozzini, A; Giraldo, P; Stagno, F; Iurlo, A; Luciani, M; De Riso, G; Redaelli, S; Kim, D; Pirola, A; Mezzatesta, C; Petroccione, A; Lodolo D'Oria, A; Crivori, P; Piazza, R; GAMBACORTI PASSERINI, C
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates
2017 Farina, F; Ceccon, M; Mori, S; Verga, L; Borin, L; Mologni, L; Fontana, D; Geeta, G; Piazza, R; Gambacorti-Passerini, C
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
2020 Diral, E; Mori, S; Antolini, L; Abruzzese, E; Le Coutre, P; Martino, B; Pungolino, E; Elena, C; Bergamaschi, M; Assouline, S; Di Bona, E; Gozzini, A; Andrade-Campos, M; Stagno, F; Iurlo, A; Pirola, A; Fontana, D; Petiti, J; Bonanomi, M; Crivori, P; Piazza, R; Fava, C; Gambacorti Passerini, C
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study
2020 Coppo, A; Bellani, G; Winterton, D; Di Pierro, M; Soria, A; Faverio, P; Cairo, M; Mori, S; Messinesi, G; Contro, E; Bonfanti, P; Benini, A; Valsecchi, M; Antolini, L; Foti, G